Evidence map›Paper›PMID 41381668›Full record

ArticleScientific reports2025

Dynamic context-aware multi-modal deep learning for longitudinal prediction of Parkinson's disease progression.

Amin Dehghanghanatkaman

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Walking as a Window to the Brain: Redefining Gait in Neurology.Medical sciences (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Amin DehghanghanatkamanDepartment of Computer Science, Shahid Bahonar University, Kerman, 76169-13439, Iran. amindgkaman@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately forecasting the progression of Parkinson's disease (PD) motor symptoms in early-to-moderate stages is essential for timely intervention and personalized patient care but remains challenging due to heterogeneous and longitudinal symptom evolution. We present a novel dynamic context-aware multi-modal deep learning framework that predicts future motor symptom severity by integrating advanced voice biomarkers with signal processing techniques, clinical progression features, demographic metadata, and semantically enriched patient summary embeddings derived from comprehensive clinical narratives via state-of-the-art natural language processing. Leveraging bidirectional LSTMs augmented with multi-head self-attention, our architecture captures complex temporal dependencies while preventing information leakage. To ensure robust evaluation despite limited sample size (42 patients), we implemented repeated 5-fold cross-validation at the patient level (8 repetitions, 40 total folds), substantially exceeding standard evaluation rigor. Our approach achieves exceptional performance ([Formula: see text] = 0.9925 ± 0.0027, RMSE = 0.67 ± 0.19, MAE = 0.50 ± 0.15) with all 40 folds achieving [Formula: see text] > 0.989, significantly outperforming classical machine learning baselines ([Formula: see text] and 0.002785) and all previously published methods on this dataset. Cross-validated ablation studies (240 total model trainings across 6 configurations) reveal that clinical features establish a strong baseline ([Formula: see text] = 0.9887 ± 0.0043), while text embeddings provide the largest incremental gain (3.82% RMSE reduction). Voice biomarkers contribute modestly to accuracy (2.72%) but substantially enhance stability (10-fold lower variability). The full multi-modal model achieves optimal performance (7.50% RMSE reduction vs. clinical-only) with the lowest variability (CV = 0.27%), demonstrating that dynamic cross-modal fusion enhances both accuracy and robustness. These findings, validated through 40 independent evaluations with each patient tested 8 times, demonstrate that integrating engineered temporal dynamics and contextual embeddings through advanced temporal modeling enables accurate longitudinal predictions of early-to-moderate PD progression. Complete code and implementation details are publicly available to ensure reproducibility.

Indexed as

Deep LearningParkinson DiseaseAgedBiomarkersDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedNatural Language ProcessingBiomarkers

Identifiers

PMID41381668
PMCPMC12808133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.